PEPD p.Ala2Val
c.5C>T · VCV4755110
Computational evidence
| Protein change | ||
| AlphaMissense | 0.4529 | ambiguous |
|---|---|---|
| REVEL | 0.496 | indeterminate |
| SaProt | LLR -9.74 | tolerated |
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 8.8 | GERP 2, phastCons 1 |
| Regional constraint | o/e 1.00 | unconstrained · MANE · 134 kb · p 0.97 · regional, not allelic |
| Overall | ||
| CADD | 28.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 0.00463% | 21,611 |
| Finnishnot grpmax-eligible | 0.00375% | 26,683 |
| Remaining individualsnot grpmax-eligible | 0.00164% | 61,128 |
| African / African-American | 0.00135% | 74,298 |
| European (non-Finnish) | 0.0006% | 166,720 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- PEPD
- Protein
- p.Ala2Val
- Coding
- c.5C>T
- MANE Select
- NM_000285
- Type
- single nucleotide variant
- Location
- chr19:33521756 (GRCh38)
- Gene constraint
- LOEUF 1.132 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 97.62 · 21 PDB
- Residue 2
- a modified residue (n-acetylalanine)
Similar variants
- PEPD p.Ala2= Likely benign ★★ same residue
- PEPD c.442-1G>C Pathogenic/Likely pathogenic ★★ same type
- PEPD c.504-1G>A Pathogenic/Likely pathogenic ★★ same type
- PEPD c.549-1G>A Pathogenic ★★ same type
- PEPD c.818+2T>G Likely pathogenic ★★ same type
- PEPD c.819-1G>A Likely pathogenic ★★ same type
- PEPD p.Ala212Pro Pathogenic/Likely pathogenic ★★ same type
- PEPD p.Arg184Ter Pathogenic ★★ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pepd-p-ala2val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown